Introduction {#Sec1}
============

Respiratory infectious diseases are common problems among children and older people worldwide especially in developing countries. Nearly 20% of mortality in children under the age of 5 years is caused by these diseases. Most respiratory tract infections, especially the upper respiratory tract ones like rhinorrhea or pharyngitis, are mild and not incapacitating. However, lower respiratory tract infections like tuberculosis, flu, pneumonia, etc. can be more severe (Fitzpatrick et al. [@CR25]). They are more likely to cause acute onset of fever, cough, dyspnea, or chest pain. Patients with respiratory infections should be diagnosed based on the disease features to expedite specific diagnosis and treatment.

This chapter is on three lower respiratory tract infections, viz., tuberculosis, influenza, and pneumonia, endogenous oxidative stress as a self-defense mechanism, and role of antioxidants on the infections.

Tuberculosis, an ancient infectious disease, can infect people of all age and almost every part of the human body. Tubercular lesions have been found on Neolithic skeletons (4500 BC) and on the bones of Egyptian mummies (1000 BC). The World Health Organization (WHO) declared that tuberculosis is among the top 10 causes of death worldwide, killing 1.6 million people in 2017 (Tuberculosis (TB) [@CR90]). Among the worst affected countries are China, Southeast Asia, and the Indian subcontinent. The disease is most common in developing countries though the Centers for Disease Control and Prevention (CDC) reported over 9000 cases in the United States in 2016. Immunosuppression by stress or other illness, malnutrition, and poor hygienic condition activates the occurrence of tuberculosis (Sia et al. [@CR78]).

Influenza, an acute respiratory infection, occurs in both pandemic and interpandemic forms. Over the past 100 years, global influenza pandemics have occurred approximately in every 10--30 years, whereas epidemic influenza occurs every winter in the temperate zones of both the hemispheres. Seasonal flu can be changed to acute respiratory illness with high mortality rate if converted to pandemic. The pathogenic H5N1 and H7N9 strains are currently in circulation and are a cause of great concern (Cline et al. [@CR12]). Senior people, young children, and people with long-term lung diseases are more prone to serious complications from the flu. Flu can make asthma symptoms worse and can increase the risk of COPD flare-up.

Pneumonia can be caused by bacteria, viruses, and fungi or from inhalation of a chemical. Pneumonia can be life threatening and a leading cause of death and hospitalization in elder people and in people with other chronic diseases. People older than 65 or younger than 2 years of age or already having health problems are susceptible to pneumonia (Metersky et al. [@CR53]).

Cells in Alveoli {#Sec2}
================

There are three major types of cells present in the alveoli, viz., alveolar cells or pneumocytes and type I and II and alveolar macrophages (Jones, [radiopaedia.org](http://radiopaedia.org))*.*

*Type I Alveolar Cells or Pneumocytes* are thin and flat and form the structure of alveoli. Type I cells take a major role in the gas exchange process between the alveoli and blood circulation. They are unable to replicate and sensitive to toxins. *Type II alveolar cells* are few in number (\< 5%), and they are mostly found at the blood-air barrier and secrete surfactants. Type II cells play a major role to protect the lung in case of damage. They undergo cellular division, giving rise to more type I and II alveolar cells, without which the alveoli would collapse. *Alveolar macrophages* or the dust cells are very important in providing the lungs protection against microorganisms. They not only engulf the microorganisms, but they also scavenge any foreign molecules like dust, carbon particles, and molecules developed from blood cell injuries. There are three types of macrophages found in lungs. Alveolar macrophages or AMΦs are found within the airways and guard the alveolar cells in bronchi, alveoli. The interstitial macrophages (IMΦs) are found in lung interstitium, while the exudate-derived macrophages, EMΦs, are recruited in response to an inflammation. These three populations are distinguishable from each other morphologically and functionally (<https://epi.publichealth.nc.gov/cd/diseases/respiratory.html>).

Role of Macrophages and Neutrophils in Combating Infections {#Sec4}
===========================================================

The major phagocytic cells of our immune system are neutrophils, dendritic cells, and macrophages (Silva Manuel and Correia [@CR80]) (Fig. [7.1](#Fig1){ref-type="fig"}). The phagocytic cells exhibit their microbicidal properties by generating huge amount of ROS and RNS within the phagosomes (Fang [@CR23]). This metabolic process or respiratory burst is most prominent in neutrophils as compared to other phagocytic cells and causes oxidative stress. Respiratory burst initiates with the assembly of the components of an enzyme complex called NADPH oxidase (Groemping and Rittinger [@CR31]) present on the plasma membrane and on the membranes of phagosomes in an inactive form. Upon phagocytosis of any molecule, assembly of the components leads to the formation of an active enzyme complex. This complex transfers one electron to O~2~ from NADPH and forms superoxide radical (O~2~^.−^) within the phagosomal lumen (Peterhans [@CR66]). The superoxides can undergo spontaneous or enzyme-catalyzed dismutation to yield H~2~O~2~ and O~2~. H~2~O~2~ combines with halides in presence of the enzyme myeloperoxidase and produces reactive hypohalous acid. These superoxide radicals may also interact with NO to produce peroxynitrite, ONOO-. These ROS/RNS can damage a variety of biomolecules and kill the ingested microorganism (Halliwell and Aruoma [@CR35]). They form adducts with unsaturated bonds and clusters having less electrons. Thus they can damage enzymes and unsaturated fatty acids or can oxidize 4Fe-4S clusters present in enzymes or proteins resulting in metabolic defects. Damaged Fe-S clusters can release Fe, which will react with H~2~O~2~ (Fenton reaction) and yield ^.^OH leading to more damage. The cysteine residues present in proteins and enzymes can also interact with H~2~O~2~ directly. Superoxides do not damage membranes in bacteria, as they lack polyunsaturated fatty acids (Fig. [7.2](#Fig2){ref-type="fig"}).Fig. 7.1Immune cells involved in fighting foreign invadersFig. 7.2Respiratory burst inside macrophage/Dendritic cell

Acidification of phagosomes is required for the optimal function of hydrolytic enzymes and thus for the degradation of the internalized pathogen. The acidification process is achieved by the recruitment of vacuolar proton-ATPase to the phagosomal membrane at the early phase of phagosome maturation. Recently it has been shown that TRPM2, the redox-sensitive transient receptor potential cation channel, expressed on the membrane of phagosome regulates the acidification and is essential for the efflux of Ca^2+^ during phagosome maturation (Di et al. [@CR15]).

The antimicrobial capacity of neutrophils is higher than that of macrophages as their cytoplasm contains granules full of multiple antimicrobial molecules and peptides like defensins, cathelicidins, and proteins like lactoferrin and bactericidal/permeability-increasing protein (Gudmundsson and Agerberth [@CR32]).

Effect of Excess ROS/RNS on Human Health {#Sec5}
========================================

The huge amounts of ROS generated as a defense mechanism against foreign molecules, if not removed adequately, will cause toxicity to all types of cells. It induces lipid peroxidation of host cell components, leading to the rise in intracellular calcium ions and DNA damage (Podinovskaia et al. [@CR68]) (Fig. [7.3](#Fig3){ref-type="fig"}). Low levels of ROS influence the growth of some viruses like influenza, paramyxoviruses, HIV, etc. Chronic OS have been found to be associated with the development of cancer in case of some viral infections (Southwick [@CR82]). Hence, antioxidants can play a major role in the treatment of viral diseases along by conventional drugs.Fig. 7.3Effect of oxidative stress on the host

Tuberculosis {#Sec6}
============

The highly aerobic and slow-growing microorganism *Mycobacterium tuberculosis* (Mtb) was discovered in 1882 by scientist Robert Koch. It can be identified with acid-fast stains or fluorescent stains under a microscope. The Mtb genome was sequenced in 1998 (Smith [@CR81]) and has been found to have more than 99.9% similarity with many other strains of *Mycobacterium*. The ability of Mtb to remain dormant in the host with the capacity to revive at a later time is because of its anaerobic persistency (Rook and Hernandez-Pando [@CR74]).

Symptoms of Tuberculosis {#Sec7}
------------------------

Symptoms of tuberculosis are characterized by cough for 3 weeks or more, coughing up cloudy mucus, sometimes with blood, loss of weight, loss of appetite, weakness, fever, night sweats, sometimes shortness of breath, and chest pain (Tuberculosis (TB) [@CR90]).

Pathophysiology of Tuberculosis {#Sec8}
-------------------------------

As discussed in the general section, macrophages kill Mtb by producing ROS/RNS in an oxygen-dependent manner. However, the bacterium has evolved mechanisms to survive inside the macrophages (Rook and Hernandez-Pando [@CR74]). Depending on the nature and site of occurrence, TB is named differently.

### Pulmonary Tuberculosis {#FPar1}

is characterized by the infection of the lung tissue by Mtb. The ROS/RNS produced by phagocytic cells restrict mycobacterial dissemination. A tuberculous lesion, called granuloma, is formed to confine the organism at the center where macrophages infected with Mtb are surrounded with noninfected phagocytes and T lymphocytes (Gengenbacher and Kaufmann [@CR29]). Release of cytokines attracts more cells in the region, and sometimes macrophages fuse together to form multinucleated cells. In severe cases, the cellular granulomas are converted to necrotizing granulomas and lead to pulmonary lesions with extensive tissue damage. The core of the granuloma, called caseum, contains dead host cells and the bacilli (Gutsmann [@CR34]).

### Extrapulmonary Tuberculosis {#FPar2}

occurs because of the spreading of the infection outside the lungs to pleura, central nervous system, lymphatic system, genitourinary system, bone, joints, and other tissues. Mostly young people and people with weakened immune system are susceptible to this kind of spreading (Lee [@CR46]).

### Active Tuberculosis {#FPar3}

is characterized by TB symptoms and highly contagious. Hence, proper treatment should be followed by people suffering from active tuberculosis.

### Latent Tuberculosis {#FPar4}

is characterized by the latency of Mtb inside the host. Most of the infected individuals with Mtb inside their macrophages don't develop the disease. Occurrence of the disease is dependent on two parameters, the virulence of the pathogen and the immune resistance of the host. The latent Mtb can become active at any time and needs proper treatment to cure the disease (Hauck et al. [@CR36]).

Entry of *M. tuberculosis* into Macrophages {#Sec9}
-------------------------------------------

There are many molecules on the macrophage surface which act as receptors for Mtb like receptors for complement factors, carbohydrate moieties, Fc region of antibodies, etc. and intercellular adhesion molecules (Ernst [@CR21]). The survival chance of Mtb depends on the receptor involved in phagocytosis. The entry of Mtb coated with specific antibodies and through receptors for antibody Fc regions would result in activation of respiratory burst in macrophages, whereas CR3 receptor-mediated entry doesn't lead to the activation of OS and thus increases the chance of survival of the bacterium (Caron and Hall [@CR8]). Host plasma membrane cholesterol (Gatfield and Pieters [@CR28]) has important roles to play in the entry of Mtb through phagocytosis and for the prevention of phagosome-lysosome fusion.

Mechanisms by Which *M. tuberculosis* Escape the Macrophage-Mediated Killing {#Sec10}
----------------------------------------------------------------------------

A macrophage membrane component, phosphatidylinositol 3-phosphate (PI3P), plays an important role in the phagosome maturation process. In Mtb-infected macrophages, Mtb glycolipids can block PI3P synthesis and thus interfere with phagosome-lysosome fusion and escape lysosome-mediated killing (Vergne et al. [@CR93]).Another strategy is to prevent accumulation of PI3P on the membrane of phagosomes by degrading it by an acid phosphatase called SapM, a 28KDa protein, secreted by Mtb within the host cell cytosol (Saleh and Belisle [@CR75]).Two protein phosphatases of Mtb, PtpA and B, interfere with host protein trafficking processes and increase the chance of survival for Mtb (Bach et al. [@CR3]).PknG, another protein kinase of Mtb, prevents the degradation of Mtb in lysosomes (Scherr et al. [@CR77]).The Mtb internalized phagosome is prevented from fusing with lysosomes by host protein coronin1/TACO and calcineurin and thereby helps in the survival of Mtb (Jayachandran et al. [@CR41]).The proteasomes of Mtb neutralize the effect of NO and thus escape RNS-mediated killing. In addition, the induction of the antimicrobial peptide cathelicidin (LL-37) is done through TLR signaling, and the process is vitamin D dependent (Fabri et al. [@CR22]).Mtb produces several proteins/enzymes that are responsible for removal or detoxification of ROS and RNS. One such protein, KatG, a catalase peroxidase, destroys hydrogen peroxide. An extracellular Mn-Fe SOD (SodA) converts superoxide radical to O~2~ and H~2~O~2~. Another Cu-Zn SOD (SodC) remains bound to the outer membrane of Mtb and possibly protects the surface against extracellular superoxides generated by host cells (Piddington et al. [@CR67]).A genome-wide interaction study performed by Nambi et al. predicted the functional relationships among three proteins, the superoxide-detoxifying enzyme (SodA), an integral membrane protein (DoxX), and possibly a thiol oxidoreductase (SseA). This oxidoreductase complex helps Mtb to survive inside the host (Nambi et al. [@CR58]).

Oxygen-Independent Clearance of *M. tuberculosis* {#Sec11}
-------------------------------------------------

Upon entry into the system, Mtb are challenged to lung epithelial cells and macrophages (Rivas-Santiago et al. [@CR73]). Infected bronchial epithelial cells produce defense molecules such as β-defensins, which directly kill the microbes by forming pores on their surface. In vitro infection of the lung epithelial cell line A549 (pneumocytes type II) with Mtb H37Rv induces the production of human beta defensin 2 (hBD-2) which is associated with mycobacterial lysis (Rivas-Santiago et al. [@CR72]) Murine beta defensins 2 and 4 are expressed by the murine bronchial epithelium cells during the early phase of progressive pulmonary tuberculosis infection.

Role of Neutrophils in Combating Mycobacterial Infections {#Sec12}
---------------------------------------------------------

It has been found through studies that neutrophils are not very much engaged in combating Mtb but may play an important role by producing important cytokines and chemokines. Blomgran and Ernst showed that use of neutrophil-specific antibody (Ly6G-specific Ab 1A8) selectively depleted neutrophils and increased the frequency of dendritic cells (DC) in the lungs. They have concluded that neutrophils infected with Mtb secrete factors that attract DCs to facilitate interactions among these cells in the lungs (Blomgran and Ernst [@CR5]).

Role of Dendritic Cells Against *M. tuberculosis* {#Sec13}
-------------------------------------------------

There are controversies regarding the role of dendritic cells against Mtb. Some studies showed that dendritic cells, after phagocytosis of the pathogens, activate the T cells. Other reports showed that Mtb inhibits DC maturation and antigen presentation to T cells. Adane Mihret reported that infection of monocyte-derived dendritic cells (MDDCs) with Mtb leads to upregulation of major histocompatibility complex (MHC) proteins and other surface proteins like CD40, CD54, CD58, and CD80 which lead to effective presentation of the antigen to the T cells (Mihret [@CR54]).

Tuberculosis and Oxidative Stress {#Sec14}
---------------------------------

It is evident from numerous studies that changes in redox status of cells result in host cellular responses that will lead to proliferation or apoptosis or cell necrosis or mutation (Choi et al. [@CR11]). This results in the damage of cell membrane resulting in fibrosis and dysfunction of lungs in pulmonary TB. Vijayamalini M et al. reported significant increase in lipid peroxidation marker, thiobarbituric acid reactive substance (TBARS), in pulmonary tuberculosis patients, both newly diagnosed and untreated, as compared to controls. The levels of antioxidants in plasma were found to decrease leading to the pathogenesis and severity of the disease (Vijayamalini and Manoharan [@CR95]).

Generation of ROS increases in TB patients coinfected with HIV. Rajopadhye et al. reported decreased NO levels in serum of TB patients, while no change was observed in patients having both HIV and TB (Rajopadhye et al. [@CR70]). There were increased levels of TBARS and CRP in both groups though increase in superoxide anion was found in HIV-TB group. Increased ROS production by the tat protein of HIV might activate NF-κB (Fiume et al. [@CR26]) and lead to the increased rate of transcription in HIV. The activities of catalase and SOD were found to decrease in TB group. Increased SOD activity and total serum protein concentration were found in both groups compared to control. Power et al. reported in their study that antioxidant supplementation along with antituberculosis treatment (ATT) for 6 months significantly decreased the MDA level and increased the levels of vitamin C and E and total antioxidant status. Hence, their study concludes that supplementation of micronutrients or antioxidants promotes recovery of patients from tuberculosis by reducing OS (Pawar et al. [@CR64]). Another work conducted by Janiszewska and group also reported that MDA concentration in the plasma of pulmonary tuberculosis patients was significantly higher before and after 1 and 2 months of antioxidant treatment with ATT compared to the control group which received only ATT (Janiszewska-Drobinska et al. [@CR40]). Wagh et al. found in their study that the levels of prooxidants were significantly increased, whereas antioxidant markers were significantly decreased in the TB population compared to healthy controls (Wagh et al. [@CR96]). In another experiment, the authors measured the OS markers and antioxidant capacity in granulomatous lesions in BCG-vaccinated and non-vaccinated guinea pigs infected with Mtb (Palanisamy et al. [@CR62]). They observed decreased serum total antioxidant capacity and increased MDA concentration within lesions in non-vaccinated guinea pigs within 2 weeks of infection which were partially restored by the treatment of N-acetyl cysteine. In addition, the antioxidant also decreased Mtb counts in the spleen and severity of lesion necrosis in the lung and spleen. Hence, proper antioxidants might be used as an adjunct therapy along with conventional ATT for better treatment and prevention of tuberculosis.

Diagnosis of TB {#Sec15}
---------------

Diagnosis of TB includes detection of presence of Mtb like Mantoux test (Nayak and Acharjya [@CR59]), sputum smear test (Desikan [@CR14]), and chest X-ray. New sensitive and rapid techniques include microscopic examination, microcolony detection, lipid profile analysis by HPLC, SDS-PAGE profiling to identify different strains of Mtb (Fatima [@CR24]), amplification of the 16S--23S rDNA spacer region, etc.

Antituberculosis Treatment (ATT) {#Sec16}
--------------------------------

### Chemotherapy {#Sec17}

ATT includes first line of drugs like isoniazid, pyrazinamide, and ethambutol and drugs like fluoroquinolones, capreomycin, kanamycin, and amikacin. The second-line drugs include thioamides, cycloserine, and aminosalicylic acid. Other second-line drugs are clofazimine, amoxicillin with clavulanate, linezolid, carbapenems, etc. (Guidelines for treatment of tuberculosis [@CR33]). Mismanagement of TB treatment can lead to resistance against multiple drugs called multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).

To eliminate tuberculosis, WHO had introduced the Directly Observed Treatment Short (DOTS) course strategy which involved health workers to keep in touch with the TB patients for proper consumption of ATT drugs. In a report published in 1996, WHO claimed that DOTS was remarkably effective in some places, whereas it failed in sub-Saharan Africa (<http://www.searo.who.int/tb/topics/what_dots/en/>).

### Administration of Antioxidants Along with ATT {#Sec18}

It has been found by many researchers that the levels of antioxidants significantly lowered down in TB compared to control. The levels again rise during and after treatment of TB (Wiid et al. [@CR97]). Reddy et al. supported the use of antioxidant supplementation for better improvement as an adjuvant therapy along with ATT (Reddy et al. [@CR71]). Lamsal et al. observed similar results while treated TB patients with micronutrients along with ATT. Micronutrient treatment reduced the oxidant levels and increased antioxidant status (Lamsal et al. [@CR45]). The supplementation also increased the production of IL-2 leading to the increased proliferation of T cells and decreased production of prostaglandin-2, T-cell suppressor. Kowalski et al. observed similar results in patients taking vitamins C and E (after 1-month ATT) (Kowalski et al. [@CR44]). Studies had showed that there exists a potential supplemental role for micronutrient and other antioxidants in management of both drug-sensitive and drug-resistant tuberculosis. The antioxidants may also have beneficial role in prevention and treatment of drug toxicity, particularly hepatotoxicity caused due to antitubercular drugs (Pawar et al. [@CR64]; Verma et al. [@CR94]).

### Prevention {#Sec19}

A live vaccine is used for a long time which was derived from an attenuated strain of *Mycobacterium bovis* called the bacille Calmette-Guérin (BCG) vaccine ([www.who.int/tb/challenges/hiv/07_tb_prevention_diagnosis_and_treatment_eng.pdf](http://www.who.int/tb/challenges/hiv/07_tb_prevention_diagnosis_and_treatment_eng.pdf)).

Influenza {#Sec20}
=========

There are four subtypes of influenza viruses, A, B, C, and D, which are very similar in overall structure. The common type, influenza A virus (IAV), infects aquatic birds, poultry animals, and humans. Influenza viruses have seven or eight pieces of --ve sense RNA as their genome which code for total 11 proteins present in the virus. HA, NA, and M2 are present on the envelope. There are about 18 HA and 11 NA subtypes known, and all possible combinations are found in wild aquatic birds though HA 1, 2, and 3 and NA 1 and 2 are commonly found in humans.

Symptoms {#Sec21}
--------

Symptoms of flu include fever, cold sweats and shivers, headache, aching joints and limbs, fatigue, feeling of exhaustion, and gastrointestinal symptoms like nausea, vomiting, and diarrhea (<http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)>).

Pathophysiology of Influenza {#Sec22}
----------------------------

Pathophysiology of influenza depends on the virulence of the flu virus and on host immune responses. Influenza virus can infect epithelial cells present both in upper and lower respiratory tract depending on the nature of the HA present on the capsid. In vivo studies showed that different IAV subtypes infect and replicate differently in the lung and thus result in different outcome (Taubenberger and Morens [@CR88]). In most cases of mild and avirulent viruses, the HA is cleaved from the viral envelope by proteases in the upper respiratory tract, and these viruses mainly infect the nose, throat, and mouth. Hence, these strains are easily transmitted among people through sneezing and coughing. The HA of strains like H5N1 can be cleaved by a variety of proteases, allowing the virus to spread throughout the body. These strains cause severe flu but are not easily spread among people. The infected cells secrete huge amount of proinflammatory cytokines and chemokines that lead to inflammation. It is believed that the virus inhibits adrenocorticotropic hormone resulting in lowered cortisol levels (Taubenberger and Morens [@CR88]). Coinfection of a susceptible cell by two IAVs at the same time can lead to antigenic shift where viral RNAs are mixed and a new shift virus strain can be generated.

Role of Macrophages in Removal of IAV {#Sec23}
-------------------------------------

IAV infects mainly the epithelial cells and alveolar macrophages (MΦs) in the respiratory tract (Nicol and Dutia [@CR60]). Tate et al. showed that viruses that readily infect MΦs in vitro were less pathogenic in vivo than viruses with a limited ability to infect MΦs (Tate Michelle et al. [@CR87]). It has also been found that infection with IAV strains that replicate productively in MΦs can induce many changes in M2 MΦs, causing them to phenotypically resemble proinflammatory M1 MΦs. Expression rate of the antibody Fc receptors (CD16 and CD32) present on MΦs surface and responsible for opsonization has been found to decrease in IAV-infected cells (Cline et al. [@CR12]).

Depletion of AMΦs in mice and pigs using clodronate (released inside the MΦs after phagocytosis and kills the cells)-loaded liposomes resulted in higher viral loads proving major role for MΦs in controlling disease severity (Duan et al. [@CR19]). Recent studies have shown that commensal microflora play an important role in the activation of pulmonary dendritic cells and induce specific immune responses against influenza virus (Samuelson et al. [@CR76]).

Role of Neutrophils on Influenza Virus {#Sec24}
--------------------------------------

Presence and increase in number of neutrophils in the airways is correlated with suppressed virus replication after flu infection (Camp and Jonsson [@CR7]). Tate et al. established the critical role of neutrophils in the clearance of influenza virus by the use of specific monoclonal antibody (RB6-8C5) against them. Neutrophil depletion leads to increased number of virus particles and increased morbidity and mortality compared to control mice (Tate Michelle et al. [@CR86]). Tumpey et al. established the role of macrophages and neutrophils in early-phase protection against an infection with a recombinant human influenza virus (H1N1) (Tumpey [@CR91]). It can be inferred that neutrophils contributed to early protection against low inoculum of the virus but not against the high inoculums indicating a limitation of PMN function. Haruo Fujisawa showed that neutrophils provide protection against influenza viruses in tumor-bearing mice with neutrophilic leukocytosis (Fujisawa [@CR27]). In vitro multiplication of influenza virus was also prevented by neutrophils from both normal and tumor-bearing mice. Addition of *N*-formylmethionyl-leucyl-phenylalanine (fMLP), a chemotactic factor and macrophage activator, to the culture, increased the inhibitory effect of neutrophils. Virus infectivity was found to decrease in the initial phase after infection in ICR and BALB/c mice though no such decrease was observed in tumor-bearing C57BU6 mice. Administration of fMLP inhibited the virus propagation in the lungs of normal and tumor-bearing mice having intranasal IAV infection. Hence, neutrophils play a significant role against IAV infection in vivo.

Influenza and Oxidative Stress {#Sec25}
------------------------------

High levels of proinflammatory cytokines, e.g., TNF-α, IFN-β, CCL5, MIP-1α (CCL3), MIP-1β (CCL4), MCP (CCL2), and IP-10 (CXCL10), have been found to be released by macrophages in humans infected with the highly pathogenic strain, H5N1 (Peschke et al. [@CR65]). Infection with seasonal IAV also results in production of cytokines and chemokines from macrophages. The number of MΦs increases in the lung in case of an IAV infection and returns to regular numbers following the resolution of the infection. Yu-Hsiang Lee et al. compared the immune responses induced by two strains of influenza virus, A/WSN/33 (H1N1) and A/Panama-like (H3N2) in C57BL/6 mice. In contrast to A/Panama-like (H3N2), WSN virus induced severe lung pathology accompanied by massive Gr-1^+^ and CD11b^+^ cell infiltration and high levels of CXCL6/GCP-2, CCL2/MCP-1, and TIMP-1 production. Both the Gr-1^+^ and CD11b^+^ cells produced ROS and RNS in lungs (Lee and Huang [@CR47]). The level of xanthine oxidase, an enzyme synthesizing O^2−^, was found to increase in lung homogenates, and cells lavaged out of the lung showed a marked increase in O^2−^ production when stimulated with phorbol myristate acetate (PMA). In another model, Oda et al. showed that intravenously injected pyran copolymer-conjugated superoxide dismutase protected mice from the lethal effect of IAV (Oda et al. [@CR61]). In addition to ROS, NO seems to play a role in the pathogenesis of IAV (Akaike et al. [@CR2]).

Increased ROS production may contribute to an increase in the influenza virus titer (Belding et al. [@CR4]). The reason lies on the effect of ROS on protease inhibitors present in the lung surfactant. The HA protein must be cleaved intracellularly into the dipeptides HA1 and HA2 for the propagation of the disease. Influenza virus strains that possess a HA that fits optimally with the intracellular protease is released into the extracellular space in the HA1/HA2 form, which is infectious. The HA that fits less optimally with the protease is released mostly in the noninfectious HA0 form (Kido et al. [@CR43]). Cleavage of HA0 can still take place by the extracellular proteases present in pulmonary surfactant. As a protective mechanism, surface of alveoli carries antiproteases. These antiproteases can be inactivated by ROS. Hence, ROS generation can result into manyfold increase in infectious virus particles. A group of workers reported that intracellular ROS levels decrease in phagocytes after influenza infection. This decrease in ROS leads to increased susceptibility to secondary infections by bacteria like *S. aureus* (Sun et al. [@CR84]).

Diagnosis {#Sec26}
---------

Diagnosis of flu includes rapid influenza diagnostic test and rapid molecular assays (George [@CR30]).

Treatment {#Sec27}
---------

The two types of anti-influenza drugs used are inhibitors of neuraminidase (oseltamivir, zanamivir, laninamivir, and peramivir) and M2 protein (adamantane derivatives) (Boltz et al. [@CR6]).

Administration of Antioxidants Along with Conventional Treatment {#Sec28}
----------------------------------------------------------------

In a study Xu and Liu showed that treatment with curcumin after IAV infection downregulated productions of cytokines in a dose-dependent manner and inhibiting NF-κB signaling pathway (Xu and Liu [@CR99]).

Prevention {#Sec29}
----------

The available trivalent vaccine protects against H1N1 and H3N2 and an influenza B virus. Another quadrivalent vaccine, available in market, provides protection against four flu viruses including an additional B virus.

Pneumonia {#Sec30}
=========

Bacterial Pneumonia {#FPar5}
-------------------

is the most occurring pneumonia in all age groups. The common causative agent of community-acquired pneumonia (CAP) is the Gram+ve bacterium *Streptococcus pneumoniae*. Other Gram+ve organisms that cause pneumonia are *Staphylococcus aureus* and *Bacillus anthracis*. Among Gram-ve bacteria, *Haemophilus influenzae*, *Klebsiella pneumoniae*, *Escherichia coli*, *Pseudomonas aeruginosa*, *Bordetella pertussis*, and *Moraxella catarrhalis* are the frequent causative agents of pneumonia. Bacteria like *Coxiella burnetii*, *Chlamydophila pneumoniae*, *Mycoplasma pneumoniae*, and *Legionella pneumophila* also have been found to cause pneumonia. *Yersinia pestis*-caused pneumonia is usually called pneumonic plague. Nowadays drug-resistant *Streptococcus pneumoniae* (DRSP) and [methicillin-resistant *Staphylococcus aureus*](https://en.wikipedia.org/wiki/Methicillin-resistant_Staphylococcus_aureus) (MRSA) have become quite common (Nair and Niederman [@CR57]).

Viral Pneumonia {#FPar6}
---------------

is caused by a number of viruses like rhinoviruses, coronaviruses, influenza viruses, respiratory syncytial viruses (RSVs), etc. Among them, RSVs are known to cause lung and airway infections in infants and young children more frequently. It is an enveloped virus with single-stranded RNA genome and belongs to the *Pneumoviridae* family of the *Mononegavirales* order (Dawson-Caswell and Muncie Jr. [@CR13]).

Mycoplasma Pneumonia {#FPar7}
--------------------

is the smallest and simplest self-limiting bacteria that cause mild upper respiratory tract infection to severe atypical pneumonia. *M. pneumonia* belongs to the class *Mollicutes* and family *Mycoplasmataceae*. They do not have cell wall and thus distinguished from bacteria. *M. pneumoniae* infections are transmitted via aerosols. Dorigo-Zetsma et al. genotyped and grouped clinical isolates of *M. pneumoniae* into eight subtypes based on P1 adhesin molecules (Dorigo-Zetsma et al. [@CR18]).

Symptoms {#Sec01}
--------

include cough sometimes with greenish or yellow mucus or bloody mucus, fever, shortness of breath, chest pain, headache, sweating, loss of appetite, low energy, and fatigue.

Pathophysiology of Pneumonia {#Sec31}
----------------------------

Neutrophils remove the microorganisms and release cytokines that result in the activation of the immune system resulting in common symptoms like fever, chills, and fatigue. Sometimes elevated immune response leads to leakage in the blood capillaries in the lungs leading to plasma seepage into the alveoli resulting in a less functional area for gas exchange. Mucus plugs are released from the leaky capillaries into blood. WBCs accumulate in the lungs to clear the plugs, and eventually cell debris accumulate in the alveoli and make it solid, called consolidation, a feature of bacterial pneumonia. Unremoved bacteria can travel to the pleural cavity and blood stream from lungs and can result in sepsis and eventually septic shock, leading to damage in multiple organs (Eddy [@CR20]).

Macrophages Against Bacterial Pneumonia {#Sec32}
---------------------------------------

AMΦs provide initial protection against bacterial pneumonia. However, when AMΦs fail, neutrophils are predominantly recruited to control the infection (Dockrell et al. [@CR16]). Aberdein et al. have shown that situations which lead to generation of less numbers of AMΦs are major causes of development of pneumonia (Aberdein et al. [@CR1]). *S. pneumoniae* is not killed by ROS as the bacterium has developed several mechanisms to escape OS-mediated killing. They are eliminated by NO and peroxynitrite, which are produced by macrophages in response to pneumococcal cell wall and the toxin pneumolysin (MacMicking et al. [@CR48]).

Neutrophils Against Bacterial Pneumonia {#Sec33}
---------------------------------------

It is known for a long time that lower respiratory tract bacterial infection causes appearance of morphologically immature neutrophils in the circulation resulting increased synthesis and release of neutrophils from the marrow. Experiments have proved that selective depletion of the neutrophils results in profound defects in the clearance of bacteria like *S. pneumoniae*, *K. pneumoniae*, and *L. pneumophila* from the lungs. Neutrophils secrete serine proteases like cathepsin G and elastase which mediate the effective killing of ingested *S. pneumoniae* (Marriott et al. [@CR50]). Investigations have also shown that efficient neutrophil accumulation is important to induce a successful adaptive immune response in the host.

Macrophages Against RSV {#Sec34}
-----------------------

The role of alveolar macrophages was studied by Philippa and coworkers in acute respiratory RSV infection by depleting macrophages by the intranasal administration of clodronate liposomes in an established mouse model (Pribul Philippa et al. [@CR69]). The decreased concentrations of local inflammatory cytokines and chemokines, less number of macrophages and natural killer cells, and enhanced viral load in the lung proved that macrophages play a central role in the early responses to viral infection. However, macrophages have been found to have little effect on the adaptive response as there was no change in the number of T cells.

Role of Neutrophils in RSV Infection {#Sec35}
------------------------------------

Neutrophils play a major role in RSV infection and lead to a strong systemic immune response. They have been found to produce the enzyme elastase and express activation markers like CD11b, CD18, and CD54 on their surface in response to RSV. The amount of neutrophil response is dependent on the clinical severity and viral load. The presence of viral genome and mRNA inside neutrophils suggests phagocytosis or replication of virions within neutrophils (Stokes et al. [@CR83]).

Immune Cells Against Mycoplasma {#Sec36}
-------------------------------

Neutrophils isolated from the airway infected with mycoplasma have been found to contain high amount of histamine compared to naive neutrophils. Mycoplasma has been found to directly stimulate the expression of mRNA encoding histidine decarboxylase, an enzyme required in histamine synthesis in vitro. Treatment with antihistamines in in vivo showed decreased severity of pneumonia and tracheobronchitis in infected mice (Xu et al. [@CR100]). Mast cells also lead to allergic inflammation by the release of histamine in mycoplasma infection. A toxin called community-acquired respiratory distress syndrome toxin (CARDS) produced by *M*. *pneumonia* promotes the generation of functional IgE in mice. Thus *M. pneumoniae*-induced infections are strongly associated with asthma and its exacerbations (Medina et al. [@CR51]).

Community-Acquired Pneumonia (CAP) and Oxidative Stress {#Sec37}
-------------------------------------------------------

Oxidative stress plays a crucial role in the development and progression of community-acquired pneumonia, the most common infectious illness. It was revealed that five times higher H~2~O~2~ is released in exhaled air of CAP patients than control and the amount decreases with treatment. The authors suggested that the sources of H~2~O~2~ were activated leucocytes, monocytes, and macrophages, and development of OS leads to the activation of neutrophils and other effector cells with generation of excess active oxygen forms in the lungs of CAP patients (Majewska et al. [@CR49]). These ROS migrate through the alveolar-capillary membrane in the process of gas exchange and are able to induce the OS development in the erythrocytes (Ugurlu [@CR92]). Trefler in their work showed increased levels of TBARS in CAP caused by bacteria compared to control. However, they observed lower TBARS levels and increased glutathione redox system in viral CAP caused by H1N1 compared to normal (Trefler et al. [@CR89]). In another study, Vilen et al. showed that there was significant increase in advanced oxidation protein products (AOPP) and MDA in blood plasma of CAP patients compared to control group though there was no change in the concentration of reactive protein carbonyl derivatives (Molotov-Luchanskiy et al. [@CR55]). Muravlyova showed that parameters like erythrocyte aggregation, total oxidant status, and OS index increased in IIP patients than controls, whereas some parameters like erythrocyte deformability, PV, and total antioxidant status remain unaltered (Muravlyova et al. [@CR56]). It has been found that postinfluenza *Staphylococcus aureus* pneumonia leads to extensive lung inflammation even after antibiotic treatment. The chronic granulomatous diseases in humans are linked to X chromosome-linked Nox2 expression (Sun et al. [@CR85]). Yuanyuan Chen et al. demonstrated increase in OS and cytokines like TNF-α and IL-6 in the lung and peripheral blood with increase in the severity of CAP. Vitamin C supplementation inhibited ROS, DNA damage, TNF-α, and IL-6 in LPS-stimulated macrophages. It also inhibited autophagy in MH-S cells exposed to LPS and H~2~O~2~ (Chen et al. [@CR10]). Rodrigo et al. observed lower FRAP and the GSH/GSSG ratio and increased lipid peroxidation in both plasma and erythrocytes in CAP than control values. Thus the antioxidant status alterations are correlated with clinical severity (Castillo et al. [@CR9]). Many studies have showed that administration of antioxidants such as Vitamins E and C have positive effects on oxidative biomarkers in in vivo and in vitro models of CAP (Siempos et al. [@CR79]). There are controversies regarding the use of vitamins in CAP though (Merchant et al. [@CR52]).

Diagnosis {#Sec02}
---------

Diagnosis of pneumonia is based on physical examinations, chest radiography, CT scan, and laboratory tests. Laboratory tests include leukocyte count, sputum Gram stain, blood cultures, pulse oximetry, and urine antigens. Recent studies open up the possibility of using OS indicators as diagnostic tools for CAP severity as well as for the estimation of effectiveness of CAP treatment (Pavlyshyn et al. [@CR63]).

Treatment {#Sec03}
---------

Treatment of pneumonia includes antibiotics to treat bacterial pneumonia and with fever and/or pain relievers (Donovan [@CR17]).

Prevention {#Sec04}
----------

Prevention of pneumonia is provided by pneumococcal conjugate vaccines against *Streptococcus pneumoniae* which are effective in children. Development of new and improved vaccines and awareness among people would lead to further improvement in strategies for the prevention of CAP.

Conclusion {#Sec38}
==========

The common lower respiratory tract infectious diseases like tuberculosis, influenza, and pneumonia can be life threatening if not treated properly. The host mechanism to fight with the microorganisms is mainly by generating ROS and RNS by the immune cells. Chronic infections and persistence of microorganisms inside the host lead to uncontrolled activation of immune system and generation of reactive species, which eventually cause enormous damage to the host system. Several studies have showed that the deleterious effects of the oxidative stress can be fought with the administration of antioxidants along with regular treatment regimen.
